1
Registered trials
1
Recruiting
1
Unique sponsors
2
Unique IMPs
0
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody
1 substance
Monoclonal antibody (rat)
1 substance
Phase II:
1
Phase II
1 trial-
RecruitingVaestra Goetalandsregionen AcademicELRANATAMAB; TECLISTAMAB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Vaestra Goetalandsregionen | Academic | 1 | Phase II | 1 |
New trials by year
2026
1